Table 2.
Reduced-intensity conditioning regimens in adults with SCD.
Conditioning Regimen | GVHD Prophylaxis | N | Age (years) |
Graft Source |
Event-free Survival |
Overall Survival |
aGVHD (≥grade 2) |
cGVHD (≥moderate) |
Reference |
---|---|---|---|---|---|---|---|---|---|
Fludarabine (150 mg/kg) Busulfan (3.2 mg/kg) Cy (29 mg/kg) ATG (15 mg/kg) Total body irradiation (200 cGy) |
|
20 | 20–45 | 20 MRD | 100% | 100% | 5% | 0% | [50] |
Fludarabine (175 mg/m2) Busulfan (13.2 mg/kg) ATG (6 mg/kg) |
|
22 | 17–36 | 17 MRD 5 MUD |
82% | 91% | 18% | 14% | [35] |
SCD, sickle cell disease; aGVHD, acute graft versus host disease; cGVHD, chronic graft versus host disease; Cy, cyclophosphamide; ATG, antithymocyte globulin; cGy, centigray; MRD, matched related donors; MUD, matched unrelated donors.